Conversely, regulatory T cells (Treg), found in both the tumor microenvironment and peripheral blood, are associated with poor prognosis across all breast cancer subtypes, with high Treg infiltration reported in 67% of HER2-enriched and 70% of basal-like breast cancers [8,9]. Here, ERBB2 is linked to neoplasm.